Search Count: 5,888
All
Selected
 |
Sars-Cov-2 Spike S2 Trimer Stabilized In The Early Fusion Intermediate Conformation (E-Fics-V3) Bound To The Vn01H1 Fab (Fab Local Refinement)
Organism: Saccharomyces cerevisiae s288c, Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2026-05-13 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Sars-Cov-2 Spike S2 Trimer Stabilized In The Early Fusion Intermediate Conformation (E-Fics-V3) Bound To The Vn01H1 Fab (S2 Local Refinement)
Organism: Saccharomyces cerevisiae s288c, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2026-05-13 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Sars-Cov-2 Spike S2 Trimer Stabilized In The Early Fusion Intermediate Conformation (E-Fics-V3) Bound To C77G12 (Fab Local Refinement)
Organism: Saccharomyces cerevisiae s288c, Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2026-05-13 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) In Complex With Covalent Inhibitor A02
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2026-05-13 Classification: HYDROLASE Ligands: A1BGG |
 |
Sars-Cov-2 Spike Trimer In The Early Fusion Intermediate Conformation Bound To The Vn01H1 Fab (Fab Local Refinement)
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2026-05-13 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Sars-Cov-2 Spike Trimer In The Early Fusion Intermediate Conformation Bound To The Vn01H1 Fab (S2 Local Refinement)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Resolution:3.30 Å Release Date: 2026-05-13 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Vicugna pacos, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Resolution:3.06 Å Release Date: 2026-05-13 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Vicugna pacos
Method: ELECTRON MICROSCOPY Resolution:3.44 Å Release Date: 2026-05-13 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
Sars-Cov-2 S2 Trimer Stabilized In The Early Fusion Intermediate Conformation By Circular Permutation And Clamping By Gp41 (E-Fics-V1)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2026-05-13 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN Ligands: A1CHJ, PO4 |
 |
Cryo-Em Structure Of The N-Terminal Domain Of Omicron Ba.1 In Complex With Nanobody N103 And S2L20 Fab
Organism: Homo sapiens, Vicugna pacos, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Resolution:2.77 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Crystal Structure Of Sars-Cov-2 S Receptor-Binding Domain (Rbd) In Complex Xg83 Fab
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:2.95 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Sars-Cov-2 Nsp14 With 1-(4-Methylphenyl)-2-(2-Methylsulfanyl-4,5-Dihydroimidazol-1-Yl)Ethanone
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1I9H, DMS, ZN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1AYN, DMS, ZN, PO4 |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1I9J, DMS, ZN, PO4 |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1I9K, DMS, ZN, PO4 |
 |
Sars-Cov-2 Nsp14 With N-Methyl-1-(2-Methyl-5-Phenylpyrazol-3-Yl)Methanamine
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: X6W, DMS, ZN, PO4 |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: A1JA8, DMS, EPE, ZN, PO4 |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: ZCW, DMS, PO4, ZN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2026-04-29 Classification: VIRAL PROTEIN Ligands: FB2, EPE, DMS, ZN, PO4 |